Amy Baggott
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- HIV/AIDS Research and Interventions 1
- Co-authors
- W.T.A. Todd (1 shared paper)Neil D Ritchie (1 shared paper)Ailsa E. McLellan (1 shared paper)Daniel Flanagan (1 shared paper)Jared S. Ellis (1 shared paper)Patrick English (1 shared paper)Richard Barton (1 shared paper)N. Kennedy (1 shared paper)
- Journals
- The Lancet (6 papers)The Lancet Diabetes & Endocrinology (1 paper)BMJ Supportive & Palliative Care (1 paper)Diabetic Medicine (1 paper)EClinicalMedicine (1 paper)
- Partner nations
- United KingdomAustraliaFrance
In The Last Decade
Amy Baggott
17 papers receiving 1.7k citations
Amy Baggott's Hit Papers
Peers
Comparison fields: 5 of 111
- Infectious Diseases 967
- Applied Microbiology and Biotechnology 50
- Neurology 347
- Internal Medicine 56
- Obstetrics and Gynecology 86
Countries citing papers authored by Amy Baggott
This map shows the geographic impact of Amy Baggott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Baggott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Baggott more than expected).
Fields of papers citing papers by Amy Baggott
This network shows the impact of papers produced by Amy Baggott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Baggott. The network helps show where Amy Baggott may publish in the future.
Co-authors
The 9 scholars most cited alongside Amy Baggott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 5 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 6 | 2023 | 83 | |
| 7 | 2012 | 68 | |
| 8 | 2018 | 31 | |
| 9 | 2023 | 24 | |
| 10 | 2024 | 23 | |
| 11 | 2010 | 14 | |
| 12 | 2017 | 8 | |
| 13 | 2025 | 5 | |
| 14 | 2014 | 2 | |
| 15 | 2025 | 2 | |
| 16 | 2020 | 1 | |
| 17 | 2023 | 1 |
About Amy Baggott
Amy Baggott is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Biochemistry, Finance and Endocrinology, Diabetes and Metabolism, having authored 17 papers that have together received 1.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Obstructive Sleep Apnea Research (1 paper), HIV/AIDS Research and Interventions (1 paper), Tracheal and airway disorders (1 paper), Yeasts and Rust Fungi Studies (1 paper), Blood transfusion and management (1 paper), Healthcare Systems and Reforms (1 paper) and Kawasaki Disease and Coronary Complications (1 paper). The work is most often cited by research in Infectious Diseases (967 citations), Applied Microbiology and Biotechnology (50 citations), Neurology (347 citations), Internal Medicine (56 citations) and Obstetrics and Gynecology (86 citations). Amy Baggott has collaborated with scholars based in United Kingdom, Australia and France. Frequent co-authors include W.T.A. Todd, Neil D Ritchie, Ailsa E. McLellan, Daniel Flanagan, Jared S. Ellis, Patrick English, Richard Barton, N. Kennedy and Andrew Nicolson. Their work appears in journals such as The Lancet, The Lancet Diabetes & Endocrinology, BMJ Supportive & Palliative Care, Diabetic Medicine and EClinicalMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.